Novotech

Today, we acknowledge World Menopause Day, an important moment to highlight the need for support, understanding, and open conversations in the workplace. Menopause is a significant transition in life that many of our colleague’s experience, and as an employer we encourage all our employees and to show care, compassion and understanding towards each other. At Novotech we believe in fostering a workplace where everyone feels seen, heard, and supported, and we believe that support, education, and open conversations are key to helping women. An excellent reference point is the International Menopause Society (IMS) website, which contains links to White Papers, Tool Kits, interviews with experts, and reports from around the world. https://lnkd.in/gyrKKFDk #WorldMenopauseDay #EmpowerHer #BreakTheStigma #MenopauseAwareness #StrongerTogether

#DidYouKnow Diffuse Large B-Cell Lymphoma (DLBCL) remains the most common and aggressive form of non-Hodgkin lymphoma? However, recent global research is driving new hope for patients. Novotech’s latest disease report on DLBCL provides an in-depth look at the current landscape of the impact of this disease, as well as information on: 🔹Breakthrough therapies like CAR T-cell treatment and immunotherapy. 🔹 The latest global clinical trials for DLBCL. 🔹Personalized treatment approaches targeting specific DLBCL subtypes. Download our FREE report for the latest updates on DLBCL research and the global clinical trial landscape. https://ow.ly/5PQ150TNii2 #DLBCL #CancerResearch #Novotech

The 2nd Annual Clinical Outsourcing Group (COG) West Coast event, held from October 8-9 in Burlingame, CA was a success. During the two day event, Aditya Kotta (Regional Director of Business Development) and Rod Bugawan, PharmD (Associate Business Development Director) engaged in discussions with biopharma industry leaders. They had the opportunity to present our comprehensive solutions and discuss ways to accelerate drug development and optimize clinical trial operations at every phase. If they missed the chance to connect or if you’d like to continue the conversation, please don’t hesitate to reach out. https://ow.ly/YPZs50TMmKa #COGWestCoast #ClinicalTrials #Novotech

Novotech embraces diverse talent and provides a supportive culture where every team member feels valued for their unique contributions while developing their fullest potential. Join Novotech today! Explore opportunities: https://lnkd.in/gBX4Mmh2 #CRA #clinicaltrials #clinicalresearch #cro #lifeatnovotech

Novotech had a productive experience at the Cell & Gene Meeting on the Mesa in Phoenix from October 7-9. Our team participated in discussions on accelerating clinical trial programs and supporting the advancement of transformative therapies. As the recipient of the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence Award 2023, Novotech continues to demonstrate its leadership in delivering innovative clinical trial solutions tailored for the cell and gene therapy space. Thanks to everyone who connected with us, we look forward to building on the valuable discussions initiated during the event. If you did not have the opportunity to connect, please feel free to reach out to discuss how Novotech can support the success of your cell and gene therapy programs. https://lnkd.in/dtz9MBVR Dimity Gransbury, Craig Leach #CGMesa2024 #Novotech #ClinicalTrials

BioJapan 2024 was an outstanding event, and Novotech was honored to participate as part of Team Australia. Novotech’s team of Hsuan-Kai (Calvin) Tzeng (Novotech’s Regional Director- Business Development), Dr. Yooni Kim (Managing Director- APAC), and Lilian K. (Senior Director- Business Development) had the pleasure of engaging with industry leaders and innovators. This event provided an excellent platform to highlight Novotech’s position as a leading global CRO with deep roots in the APAC region, while exploring opportunities to accelerate clinical trial programs for sponsors and partners. If you missed the opportunity to connect during the event, we invite you to reach out to us here. https://lnkd.in/dM63Cfta #BioJapan2024 #Novotech #TeamAustralia

Join Novotech at the Veeva Korea Summit 2024, one of the largest events in the pharmaceutical and biotechnology industry in the region on October 15, 2024, at the Grand Intercontinental Seoul Parnas. This event will bring together professionals from R&D in clinical, manufacturing, licensing, and pharmacovigilance to sales, medical, and marketing, to learn about the latest industry trends, expert insights, and customer innovation in the industry. SangHee Kim, Country Managing Director of Novotech Korea, will serve as a panelist for the session “𝙃𝙤𝙬 𝙛𝙖𝙧 𝙝𝙖𝙨 𝙩𝙝𝙚 𝙆𝙤𝙧𝙚𝙖𝙣 𝙘𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙩𝙧𝙞𝙖𝙡 𝙞𝙣𝙙𝙪𝙨𝙩𝙧𝙮 𝙘𝙤𝙢𝙚 𝙞𝙣 𝙞𝙩𝙨 𝙙𝙞𝙜𝙞𝙩𝙖𝙡 𝙩𝙧𝙖𝙣𝙨𝙛𝙤𝙧𝙢𝙖𝙩𝙞𝙤𝙣?”. During this session, SangHee will share her insights on the advantages of digitalization, offer practical experiences, and discuss key challenges that lie ahead in advancing digital transformation within the industry. The panel discussion will take place from 1:30 pm - 2:30 pm as part of the Afternoon Sessions 1 program. Don’t miss out on this impactful discussion! #Novotech #Veeva #CRO

Press Pause and Recharge Take an extended unpaid leave to pursue personal interests or responsibilities. We support your need for rejuvenation and work-life balance. Follow us to learn more at Novotech #lifeatnovotech #cra #clinicaltrials #clinicalresearch #clinicalresearchassociate #cro

#DidYouKnow Cell and gene therapies are projected to grow at an annual rate of 36% through 2030? These therapies are playing an increasingly important role in healthcare by offering personalized treatment options for diseases that were previously difficult or impossible to treat. As part of the precision medicine approach, they target the underlying genetic causes of disease. Novotech’s 2024 Cell & Gene Therapy Global Clinical Trial Landscape report provides an in-depth overview of the state of cell and gene therapies, with a focus on innovations like CAR-T and CAR-NK therapies, particularly in the areas of cancer and rare genetic disorders. The report also examines global trends, including the Asia-Pacific region’s role in driving faster patient recruitment and clinical trial growth. These therapies represent a key development in the ongoing effort to advance treatment options for conditions such as hematologic cancers and rare genetic diseases. https://lnkd.in/dDYfXS8z #Novotech #GenTherapy #ClinicalTrials

We’re pleased to announce that Dr. David Ng, Vice President of Global Biometrics at Novotech, will be a featured speaker at the 16th Annual Outsourcing in Clinical Trials New England event, taking place October 23 - 24, 2024 at the Westin Boston Seaport, in Boston, Massachusetts. With over 30 years of expertise in data management, statistics, and regulatory interactions, Dr. Ng will offer his insights on Biometrics Considerations in Implementing New Technology. 🔹 When: October 24, 9:30 AM EDT 🔹 Where: Stream B We look forward to the opportunity to connect with you at the event. https://lnkd.in/dr6GtTgB #OCTNE2024 #Novotech #Biometrics